Larvol Delta - AVENU-Study-of-MRx0518-and-Avelumab-in-Patients-With-Urothelial-Carcinoma

Bavencio (avelumab) - EMD Serono, Pfizer

MRx0518 - 4D Pharma

http://clinicaltrials.gov/ct2/show/NCT05107427

Mar 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next